Had an appointment privately to discuss HIFU last week after research about this been the niche treatment for low level cancers grade 3 + 3 Gleason.
I was informed that the probe does not remove all the cancer and leaves some behind which I find disappointing which then further treatment may be required in another 5 years + time. This is not the niche treatment in terms of a cure; hence I presume why it is not widely available on the NHS due to minimising the cancer rather than curing? The only benefit it seems is that it is less invasive and has a better outcome preserving sexual function and continence, but it is just delaying the inevitable second treatment option.
One question I did not ask was ‘why all the cancer is not targeted by the probe,’ has anyone got any answers to this please. Is it because the probe cannot reach all the areas? and the more areas targeted may cause more side effects? The next step is to have an advanced MPI MRI to be carried out in London to pinpoint a target area , it seems the basic MRI done in the NHS does not give a true picture if the cancer is low grade as the private specialist said the volume of cancer, although slow growing, is greater than what I was told in the NHS.
Other peoples experience and views about these points will be appreciated.
It is likely the RP is the favourable route now to eradicate the localised cancer. Staying on Active Surveillance is obviously a benefit in the short term eventually treatment will have to happen.